Loading insider details...
Beta
Latest Form 4 (Jul 24, 2026): Tax Withholding of 22,516 VYNE shares, $20.2K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 24, 2026 | VYNE Therapeutics Inc. (VYNE) | Tax Withholding | 22,516 | $20.2K |
| Jul 3, 2026 | VYNE Therapeutics Inc. (VYNE) | Tax Withholding | 3,464 | $2.3K |
| Apr 2, 2026 | VYNE Therapeutics Inc. (VYNE) | Tax Withholding | 4,007 | $2.4K |
| Jan 5, 2026 | VYNE Therapeutics Inc. (VYNE) | Tax Withholding | 3,579 | $2.1K |
| Oct 2, 2025 | VYNE Therapeutics Inc. (VYNE) | Tax Withholding | 3,581 | $1.2K |
| Jul 2, 2025 | VYNE Therapeutics Inc. (VYNE) | Tax Withholding | 3,581 | $5.9K |
| Jun 3, 2025 | VYNE Therapeutics Inc. (VYNE) | Grant/Award | 1,145 | $927.45 |
| Apr 2, 2025 | VYNE Therapeutics Inc. (VYNE) | Tax Withholding | 8,828 | $13.9K |
| Jan 23, 2025 | VYNE Therapeutics Inc. (VYNE) | Grant/Award | 230,000 | n/a |
| Jan 2, 2025 | VYNE Therapeutics Inc. (VYNE) | Tax Withholding | 4,697 | $15.7K |